The Galien Foundation is excited to announce Ariel Katz, Co-founder and CEO of H1, as a distinguished member of the 2024 Prix Galien USA Digital Health Advisory Board. Katz, recognized for his leadership in driving innovation in health technology and data-driven healthcare solutions, brings a wealth of experience that will significantly contribute to shaping the future of digital health. With a background in leveraging data to improve healthcare outcomes, Katz will help evaluate groundbreaking solutions that address critical healthcare challenges, reinforcing Prix Galien USA's mission to honor innovations that advance healthcare. We are thrilled to see Ariel Katz contribute to the advisory board and help spotlight transformative healthcare technologies. #PrixGalienUSA #HealthcareInnovation #DigitalHealth #ArielKatz #LifeSciences #GalienFoundation #HealthTech #MedicalInnovation
Nice work Ariel !! ??
Awesome. Congratulations Ariel Katz !
Congratulations, Ariel Katz ??
Congrats Ariel Katz ???? Well deserved
Congrats Ariel for this recognition! Best wishes...
Congratulations, Ariel!
Qualified Person for Pharmacovigilance (QPPV) @ Surgipharm Uganda Ltd. | Health Technology Assessment
20 小时前Congratulations for bringing on board much needed and unique skills which are timely for the future of innovation.